-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Ani Pharmaceuticals Inc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2010 to 2021.
- Ani Pharmaceuticals Inc Depreciation, Depletion and Amortization for the quarter ending March 31, 2022 was $14.6M, a 33.6% increase year-over-year.
- Ani Pharmaceuticals Inc Depreciation, Depletion and Amortization for the twelve months ending March 31, 2022 was $50.9M, a 14.8% increase year-over-year.
- Ani Pharmaceuticals Inc annual Depreciation, Depletion and Amortization for 2021 was $47.3M, a 5.86% increase from 2020.
- Ani Pharmaceuticals Inc annual Depreciation, Depletion and Amortization for 2020 was $44.6M, a 0.06% increase from 2019.
- Ani Pharmaceuticals Inc annual Depreciation, Depletion and Amortization for 2019 was $44.6M, a 32.2% increase from 2018.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)